Pfizer Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pfizer Ltd. on BSE

Search Inside the pdf :

Pfizer Ltd.

12 Nov 2025, 03:37PM

5043.50

0.56%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial …

BSE India

Pursuant to Regulations 30 and 33 of the Listing Regulations, we submit herewith the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025, which were inter alia approved by the Board of Directors of the Company at their Meeting held today i.e., November 12, 2025, that commenced at 2.00 p.m. and concluded at 3.15 p.m.

pdf

Pfizer Ltd.

03 Nov 2025

5043.50

0.56%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting To Consider And Approve The …

BSE India

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 12, 2025 inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025.

pdf

Pfizer Ltd.

08 Oct 2025

5043.50

0.56%

Company Update

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.

pdf

Pfizer Ltd.

13 Aug 2025, 05:04PM

5043.50

0.56%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial …

BSE India

Unaudited Financial Results for quarter ended June 30, 2025

pdf

Pfizer Ltd.

13 Aug 2025, 04:58PM

5043.50

0.56%

Result

Pfizer Ltd - 500680 - Outcome Of Board Meeting - Unaudited Financial Results For The Quarter …

BSE India

Unaudited Financial results for the quarter ended June 30, 2025

pdf

Pfizer Ltd.

11 Aug 2025

5043.50

0.56%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pfizer Launches 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV20) for Adults in India, offering broad protection against Pneumococcal Disease.

pdf

Pfizer Ltd.

11 Aug 2025

5043.50

0.56%

Company Update

Pfizer Ltd - 500680 - Launch Of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - Valent …

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we hereby inform that Company has announced the launch of its next generation 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - valent (PCV20) for adults in India, on August 11, 2025.

pdf

Pfizer Ltd.

07 Aug 2025

5043.50

0.56%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting To Consider And Approve The …

BSE India

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 13, 2025 inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2025.

pdf

Pfizer Ltd.

22 Jul 2025

5043.50

0.56%

AGM

Pfizer Ltd - 500680 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44 of SEBI (LODR) Regulations, 2015, we submit herewith the consolidated scrutinizer''s report of the votes cast during electronic voting and electronic polling process conducted during the 74th Annual General Meeting of the Company held on Monday, July 21, 2025 at 3.00 P.M. IST.

pdf